US OptionsDetailed Quotes

STKL241220C4000

Watchlist

1.60
0.000.00%

15min DelayClose Nov 29 13:00 ET

0.00High0.00Low

SunOpta Stock Discussion

Stock_Drift

Sep 16 08:19

$SunOpta (STKL.US)$

Moomoo AI

Feb 29 11:22

CEO Brian Kocher is highly confident in the business's direction, reaffirming the 2024 outlook. The company's growth is expected to be driven by nutritional beverages expansion and Better-For-You snacking segment acceleration.

SunOpta Rallies to 8-month High on Q4 Results

Moomoo AI

Nov 11, 2023 06:23

Significant downgrade in SunOpta's revenue estimates raises concern. Analysts predict the business's sales growth lags, hinting SunOpta's performance to trail the wider industry.

Analysts Just Made A Major Revision To Their SunOpta Inc. (NASDAQ:STKL) Revenue Forecasts

👀

SunOpta CEO marks the sale as a key point in transforming to concentrate on plant-based and healthy snack segments. The move is expected to boost margins, enable a more capital-efficient model, strengthen finances and pave way for attractive growth opportunities.

SunOpta Exits Frozen Fruit Business Through Asset Sale, Releases Preliminary Q3 Results

Stocks with Josh

Oct 18, 2022 21:33

+Technical Tuesday Stocks of Interest

3 Value Stocks to Buy Now | Technical Tuesdays

From YouTube

Moomoo Breakfast US

Jun 3, 2022 07:29

Columns Today's pre-market stock movers: TSLA, CHGG, OKTA, TPTX and more

Gainers:
• $Okta (OKTA.US)$ +15.8% (In reaction to earnings)
• $StoneCo (STNE.US)$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics (TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals (AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...

MS159

May 13, 2021 11:19

$SunOpta (STKL.US)$

No comment yet